ELBadawy Nissreen E, Abdel-Latif Randa S, El-Hady Hoda A
Department of Medical Microbiology & Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Egypt J Immunol. 2017 Jan;24(1):165-181.
Atopic bronchial asthma is chronic respiratory diseases of high frequency and high morbidity and mortality especially in patients refractory to the ordinary medical management. This study aimed to investigate the association between Serpin family B Member 2 (SERPINB2) gene expression and bronchial asthma severity. A total of 127 adult patients with asthma were enrolled in this study. Allergic respiratory symptoms were assessed and patients were classified according to Global Initiative for Asthma (GINA) criteria. The patients were subjected to skin prick test (SPT) by commonly encountered aeroallergens and pulmonary function tests. Sputum samples were subjected to RNA extraction and real time PCR amplification (q PCR) of SERPINB2 mRNA. The relative gene expression was determined by fold change (2-??Ct) after calculation of delta-delta Ct (Cycle threshold of patients- Cycle threshold of healthy control). Assessment of the q PCR results was done by Receiver operating characteristic curve (ROC). Patients with severe bronchial asthma constituted 44% of asthma patients and mild asthma 22% of asthmatics. SPT revealed that 23 % of the patients were mono-sensitized and 77 % were poly-sensitized. The mites and pollens were the most frequently sensitizing allergens detected by SPT (53%, and 47%, respectively. SERPINB2 gene expression in asthma group that discriminated them from healthy control was > 0.01. The highest increase of expression was found ( > 1.92 fold) severe asthma compared to the mild group. A negative correlation was found between SERPINB2 expression and pulmonary function tests FEV1/FVC % and FEV1% (r?=?-0.921 and -0.805, P < 0.001), respectively. While significant positive correlation was found between SERPINB2 expression and total IgE levels (r?=?0.932 and P-value < 0.001), and SPT results (r?=?0.923 and P-value < 0.001). In conclusion, the expression level of SERPINB2 gene significantly correlated with the severity of bronchial asthma.
特应性支气管哮喘是一种高频慢性呼吸道疾病,发病率和死亡率高,尤其是在对常规治疗难治的患者中。本研究旨在探讨丝氨酸蛋白酶抑制剂家族B成员2(SERPINB2)基因表达与支气管哮喘严重程度之间的关联。本研究共纳入127例成年哮喘患者。评估过敏呼吸道症状,并根据全球哮喘防治创议(GINA)标准对患者进行分类。患者接受常见气传变应原的皮肤点刺试验(SPT)和肺功能测试。对痰样本进行RNA提取和SERPINB2 mRNA的实时PCR扩增(q PCR)。在计算Δ-ΔCt(患者的循环阈值-健康对照的循环阈值)后,通过倍数变化(2-ΔΔCt)确定相对基因表达。通过受试者工作特征曲线(ROC)评估q PCR结果。重度支气管哮喘患者占哮喘患者的44%,轻度哮喘患者占哮喘患者的22%。SPT显示,23%的患者为单敏,77%的患者为多敏。SPT检测到的最常见致敏变应原是螨虫和花粉(分别为53%和47%)。哮喘组中与健康对照有差异的SERPINB2基因表达>0.01。与轻度组相比,重度哮喘组的表达增加最高(>1.92倍)。SERPINB2表达与肺功能测试FEV1/FVC%和FEV1%之间分别存在负相关(r=-0.921和-0.805,P<0.001)。而SERPINB2表达与总IgE水平(r=0.932,P值<0.001)和SPT结果(r=0.923,P值<0.001)之间存在显著正相关。总之,SERPINB2基因的表达水平与支气管哮喘的严重程度显著相关。